Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enact Holdings (ACT) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Enact Holdings (ACT) over the last 6 years, with Q3 2025 value amounting to $543.6 million.

  • Enact Holdings' Cash & Equivalents fell 1927.43% to $543.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $543.6 million, marking a year-over-year decrease of 1927.43%. This contributed to the annual value of $599.4 million for FY2024, which is 263.95% down from last year.
  • Enact Holdings' Cash & Equivalents amounted to $543.6 million in Q3 2025, which was down 1927.43% from $613.0 million recorded in Q2 2025.
  • Enact Holdings' Cash & Equivalents' 5-year high stood at $699.0 million during Q2 2024, with a 5-year trough of $425.8 million in Q4 2021.
  • Its 5-year average for Cash & Equivalents is $584.5 million, with a median of $613.0 million in 2025.
  • As far as peak fluctuations go, Enact Holdings' Cash & Equivalents skyrocketed by 4122.61% in 2023, and later crashed by 1927.43% in 2025.
  • Enact Holdings' Cash & Equivalents (Quarter) stood at $425.8 million in 2021, then rose by 20.65% to $513.8 million in 2022, then rose by 19.84% to $615.7 million in 2023, then fell by 2.64% to $599.4 million in 2024, then dropped by 9.32% to $543.6 million in 2025.
  • Its Cash & Equivalents was $543.6 million in Q3 2025, compared to $613.0 million in Q2 2025 and $635.3 million in Q1 2025.